Atherosclerosis
Volume 217, Issue 1 , Pages 3-46 , July 2011

ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)

Developed with the special contribution of: European Association for Cardiovascular Prevention & Rehabilitation.

  • Alberico L. Catapano (EAS Chairperson, Italy)

      Affiliations

    • Other ESC entities having participated in the development of this document: Associations: Heart Failure Association. Working Groups: Cardiovascular Pharmacology and Drug Therapy, Hypertension and the Heart, Thrombosis. Councils: Cardiology Practice, Primary Cardiovascular Care, Cardiovascular Imaging. The content of these European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) Guidelines has been published for personal and educational use only. No commercial use is authorized. No part of the ESC Guidelines may be translated or reproduced in any form without written permission from the ESC. Permission can be obtained upon submission of a written request to Oxford University Press, the publisher of the European Heart Journal and the party authorized to handle such permissions on behalf of the ESC.
    • Corresponding Author InformationCorresponding author at: Department of Pharmacological Science, University of Milan, Via Balzaretti, 9, 20133 Milano, Italy. Tel.: +39 02 5031 8302; fax: +39 02 5031 8386.
    • ,
  • Željko Reiner (ESC Chairperson, Croatia)

      Affiliations

    • Corresponding Author InformationCorresponding author at: University Hospital Center Zagreb, School of Medicine, University of Zagreb, Salata 2, 10 000 Zagreb, Croatia. Tel.: +385 1 492 0019; fax: +385 1 481 8457.
    • ,
  • Guy De Backer (Belgium)
    • ,
  • Ian Graham (Ireland)
    • ,
  • Marja-Riitta Taskinen (Finland)
    • ,
  • Olov Wiklund (Sweden)
    • ,
  • Stefan Agewall (Norway)
    • ,
  • Eduardo Alegria (Spain)
    • ,
  • M. John Chapman (France)
    • ,
  • Paul Durrington (UK)
    • ,
  • Serap Erdine (Turkey)
    • ,
  • Julian Halcox (UK)
    • ,
  • Richard Hobbs (UK)
    • ,
  • John Kjekshus (Norway)
    • ,
  • Pasquale Perrone Filardi (Italy)
    • ,
  • Gabriele Riccardi (Italy)
    • ,
  • Robert F. Storey (UK)
    • ,
  • David Wood (UK)
    • ,
  • Authors/Task Force Members: ESC Committee for Practice Guidelines (CPG) 2008–2010 and 2010–2012 Committees: Jeroen Bax (CPG Chairperson 2010–2012) (The Netherlands)
    • ,
  • Alec Vahanian (CPG Chairperson 2008–2010) (France)
    • ,
  • Angelo Auricchio (Switzerland)
    • ,
  • Helmut Baumgartner (Germany)
    • ,
  • Claudio Ceconi (Italy)
    • ,
  • Veronica Dean (France)
    • ,
  • Christi Deaton (UK)
    • ,
  • Robert Fagard (Belgium)
    • ,
  • Gerasimos Filippatos (Greece)
    • ,
  • Christian Funck-Brentano (France)
    • ,
  • David Hasdai (Israel)
    • ,
  • Richard Hobbs (UK)
    • ,
  • Arno Hoes (The Netherlands)
    • ,
  • Peter Kearney (Ireland)
    • ,
  • Juhani Knuuti (Finland)
    • ,
  • Philippe Kolh (Belgium)
    • ,
  • Theresa McDonagh (UK)
    • ,
  • Cyril Moulin (France)
    • ,
  • Don Poldermans (The Netherlands)
    • ,
  • Bogdan Popescu (Romania)
    • ,
  • Željko Reiner (Croatia)
    • ,
  • Udo Sechtem (Germany)
    • ,
  • Per Anton Sirnes (Norway)
    • ,
  • Michal Tendera (Poland)
    • ,
  • Adam Torbicki (Poland)
    • ,
  • Panos Vardas (Greece)
    • ,
  • Petr Widimsky (Czech Republic)
    • ,
  • Stephan Windecker (Switzerland)

Title About Type File Size
APPLICATION Other 2 MB

Please note that add-on components may require plug-in applications.

☆ Disclaimer: The ESC Guidelines represent the views of the ESC and the EAS, and were arrived at after careful consideration of the available evidence at the time they were written. Health professionals are encouraged to take them fully into account when exercising their clinical judgement. The guidelines do not, however, override the individual responsibility of health professionals to make appropriate decisions in the circumstances of the individual patients, in consultation with that patient, and where appropriate and necessary the patient's guardian or carer. It is also the health professional's responsibility to verify the rules and regulations applicable to drugs and devices at the time of prescription.

☆☆ The disclosure forms of the authors and reviewers are available on the ESC website www.escardio.org/guidelines.

PII: S0021-9150(11)00548-X

doi: 10.1016/j.atherosclerosis.2011.06.028

Atherosclerosis
Volume 217, Issue 1 , Pages 3-46 , July 2011

Article Tools

* Image Usage & Resolution